OncoDaily IO (@oncodailyio) 's Twitter Profile
OncoDaily IO

@oncodailyio

Your daily source for the latest updates, insights, and news in immuno-oncology. #OncoDailyIO #OncoDaily #immunooncology #immuneoncology #immunotherapy

ID: 1830630020613636096

linkhttp://oncodaily.com calendar_today02-09-2024 15:33:24

589 Tweet

1,1K Followers

6,6K Following

OncoDaily IO (@oncodailyio) 's Twitter Profile Photo

Rare but Deadly - ICIs Can Trigger Myocarditis and Myositis - Dr Rishabh Jain oncodaily.com/science/rishab… #ICIs #Myocarditis #Myositis #Immunotherapy #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews

Rare but Deadly - ICIs Can Trigger Myocarditis and Myositis - <a href="/DrRishabhOnco/">Dr Rishabh Jain</a> 

oncodaily.com/science/rishab…

#ICIs #Myocarditis #Myositis #Immunotherapy #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews
OncoDaily IO (@oncodailyio) 's Twitter Profile Photo

Pemigatinib for Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement - J.J. Kiladjian oncodaily.com/science/jean-j… NEJM Evidence Stephen Oh #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews

Pemigatinib for Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement - <a href="/jjkiladjian/">J.J. Kiladjian</a> 

oncodaily.com/science/jean-j…

<a href="/NEJMEvidence/">NEJM Evidence</a>  <a href="/mpndoc/">Stephen Oh</a>

#Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews
OncoDaily IO (@oncodailyio) 's Twitter Profile Photo

Matt Sherer Highlights Muhammad Bilal Abid’s Insights on Immune Protection and CAR T Therapy oncodaily.com/science/matt-s… Matt Sherer,FACHE 🥋🐘 #RollTide #cancer #oncology Bilal Abid, MD, MS #ImmuneProtection #Immunotherapy #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews

Matt Sherer Highlights Muhammad Bilal Abid’s Insights on Immune Protection and CAR T Therapy

oncodaily.com/science/matt-s…

<a href="/MattSherer2/">Matt Sherer,FACHE 🥋🐘 #RollTide #cancer #oncology</a> <a href="/BilalAbidMD/">Bilal Abid, MD, MS</a> 

#ImmuneProtection #Immunotherapy #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews
OncoDaily IO (@oncodailyio) 's Twitter Profile Photo

Walking the Dam to Dam for Cancer Research - Myriam Chalabi oncodaily.com/voices/myriam-… #CancerResearch #Immunotherapy #ImmuneOnc #ColonCancer #StomachCancer #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews

Walking the Dam to Dam for Cancer Research - <a href="/MyriamChalabi/">Myriam Chalabi</a>

oncodaily.com/voices/myriam-…

#CancerResearch #Immunotherapy #ImmuneOnc #ColonCancer #StomachCancer #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews
CancerWorld (@cancerworldmag) 's Twitter Profile Photo

📢CancerWorld #107 is LIVE📢 We are happy to present the September issue of CancerWorld, bringing together powerful voices and ideas you won’t want to miss. 📍In this issue, we spotlight: 🔹Dr. Patrick Soon-Shiong Dr. Pat Soon-Shiong , in one of our dual cover features, shares

📢CancerWorld #107 is LIVE📢

We are happy to present the September issue of CancerWorld, bringing together powerful voices and ideas you won’t want to miss.

📍In this issue, we spotlight:

🔹Dr. Patrick Soon-Shiong <a href="/DrPatSoonShiong/">Dr. Pat Soon-Shiong</a> , in one of our dual cover features, shares
OncoDaily IO (@oncodailyio) 's Twitter Profile Photo

Interferon Epsilon Loss and Immune-Cold Tumors - Vun-Sin Lim, PhD oncodaily.com/voices/vun-sin… #Immunotherapy #ImmuneOnc #ImmuneColdTumors #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews

Interferon Epsilon Loss and Immune-Cold Tumors - <a href="/vs_lim/">Vun-Sin Lim, PhD</a> 

oncodaily.com/voices/vun-sin…

#Immunotherapy #ImmuneOnc #ImmuneColdTumors #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews
OncoDaily IO (@oncodailyio) 's Twitter Profile Photo

Using the EpiSwitch CIRT Test to Assess the Likelihood of Response to Immunotherapy - Kashyap Patel, MD oncodaily.com/science/kashya… #Immunotherapy #ImmuneOnc #IO #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews

Using the EpiSwitch CIRT Test to Assess the Likelihood of Response to Immunotherapy - <a href="/KashyappatelMd/">Kashyap Patel, MD</a> 

oncodaily.com/science/kashya…

#Immunotherapy #ImmuneOnc #IO #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews
OncoDaily IO (@oncodailyio) 's Twitter Profile Photo

Remarkable Study on the Ontogeny of Neoantigen-Specific CD4+ T Cell Responses - Stephen P. Schoenberger oncodaily.com/science/stephe… Journal for ImmunoTherapy of Cancer #TCellResponses #Immunotherapy #IO #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews

Remarkable Study on the Ontogeny of Neoantigen-Specific CD4+ T Cell Responses - Stephen P. Schoenberger 

oncodaily.com/science/stephe…

<a href="/jitcancer/">Journal for ImmunoTherapy of Cancer</a> 

 #TCellResponses #Immunotherapy #IO #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews
OncoDaily IO (@oncodailyio) 's Twitter Profile Photo

The pre-T Cell Receptor as an Immunotherapy Target in T Cell Leukemia - Iannis Aifantis Nature Immunology oncodaily.com/science/t-cell… #Cancer #ImmuneOnc #IO #ImmunoOncology #Immunotherapy #MedEd #MedX #MedNews #Health #Medicine #OncoDaily #Oncology

The pre-T Cell Receptor as an Immunotherapy Target in T Cell Leukemia - <a href="/iannisaifantis1/">Iannis Aifantis</a> 

<a href="/NatImmunol/">Nature Immunology</a> 

oncodaily.com/science/t-cell…

#Cancer #ImmuneOnc #IO #ImmunoOncology #Immunotherapy #MedEd #MedX #MedNews #Health #Medicine #OncoDaily #Oncology
OncoDaily IO (@oncodailyio) 's Twitter Profile Photo

Is a Cure Possible with TIL? - Pauline Funchain Allison Betof, MD, PhD @stanfordcancer oncodaily.com/voices/is-a-cu… #Cancer #ImmuneOnc #IO #ImmunoOncology #Immunotherapy #MedEd #MedX #MedNews #Health #Medicine #OncoDaily #Oncology

Is a Cure Possible with TIL?  - <a href="/FunchainMD/">Pauline Funchain</a> 

<a href="/DrBetofMDPhD/">Allison Betof, MD, PhD</a> @stanfordcancer 

oncodaily.com/voices/is-a-cu…

#Cancer #ImmuneOnc #IO #ImmunoOncology #Immunotherapy #MedEd #MedX #MedNews #Health #Medicine #OncoDaily #Oncology
OncoDaily IO (@oncodailyio) 's Twitter Profile Photo

Allowing Immune System to Cure the Cancer - Dr. Pat Soon-Shiong oncodaily.com/url/365182 #Cancer #ImmuneOnc #IO #ImmunoOncology #Immunotherapy #MedEd #MedX #MedNews #Health #Medicine #OncoDaily #Oncology

Allowing Immune System to Cure the Cancer - <a href="/DrPatSoonShiong/">Dr. Pat Soon-Shiong</a> 

oncodaily.com/url/365182

#Cancer #ImmuneOnc #IO #ImmunoOncology #Immunotherapy #MedEd #MedX #MedNews #Health #Medicine #OncoDaily #Oncology
OncoDaily IO (@oncodailyio) 's Twitter Profile Photo

The First Showcase of the Hwang Lab at Ulsan National Institute of Science and Technology - Sung-Min Hwang Ph.D. oncodaily.com/voices/sung-mi… #Cancer #ImmuneOnc #IO #ImmunoOncology #Immunotherapy #MedEd #MedX #MedNews #Health #Medicine #OncoDaily #Oncology

The First Showcase of the Hwang Lab at Ulsan National Institute of Science and Technology - <a href="/SMHwang_PhD/">Sung-Min Hwang Ph.D.</a> 

oncodaily.com/voices/sung-mi…

#Cancer #ImmuneOnc #IO #ImmunoOncology #Immunotherapy #MedEd #MedX #MedNews #Health #Medicine #OncoDaily #Oncology
OncoDaily IO (@oncodailyio) 's Twitter Profile Photo

Contribution of IO in TKI/IO Combinations For Non-Clear Cell Kidney Cancer - Sumanta K. Pal, MD, FASCO oncodaily.com/voices/sumanta… #Cancer #ImmuneOnc #IO #ImmunoOncology #Immunotherapy #MedEd #MedX #MedNews #Health #Medicine #OncoDaily #Oncology

Contribution of IO in TKI/IO Combinations For Non-Clear Cell Kidney Cancer - <a href="/montypal/">Sumanta K. Pal, MD, FASCO</a> 

oncodaily.com/voices/sumanta…

#Cancer #ImmuneOnc #IO #ImmunoOncology #Immunotherapy #MedEd #MedX #MedNews #Health #Medicine #OncoDaily #Oncology
OncoDaily IO (@oncodailyio) 's Twitter Profile Photo

Joshua Reuss (Joshua Reuss) Highlights Neoadjuvant Immunotherapy Trial for Mesothelioma in Nature Medicine - Patrick Forde (Patrick Forde) oncodaily.com/insight/patric… #Cancer #ImmuneOnc #IO #ImmunoOncology #Immunotherapy #MedEd #MedX #MedNews #Health #Medicine #OncoDaily #Oncology

Joshua Reuss (<a href="/Joshua_Reuss/">Joshua Reuss</a>) Highlights Neoadjuvant Immunotherapy Trial for Mesothelioma in Nature Medicine - Patrick Forde (<a href="/FordePatrick/">Patrick Forde</a>)

oncodaily.com/insight/patric…

#Cancer #ImmuneOnc #IO #ImmunoOncology #Immunotherapy #MedEd #MedX #MedNews #Health #Medicine #OncoDaily #Oncology
OncoDaily IO (@oncodailyio) 's Twitter Profile Photo

Might Induction ChemoIO Be a Better Route for Lung Cancer? - Gerry Hanna (Gerry Hanna) oncodaily.com/voices/gerry-h… #Cancer #ImmuneOnc #IO #ImmunoOncology #Immunotherapy #MedEd #MedX #MedNews #Health #Medicine #OncoDaily #Oncology

Might Induction ChemoIO Be a Better Route for Lung Cancer? - Gerry Hanna (<a href="/gerryhanna/">Gerry Hanna</a>)

oncodaily.com/voices/gerry-h…

#Cancer #ImmuneOnc #IO #ImmunoOncology #Immunotherapy #MedEd #MedX #MedNews #Health #Medicine #OncoDaily #Oncology
OncoDaily (@oncodaily) 's Twitter Profile Photo

🚨 Highlights from VIRO 2025 (Global Voices in Renal Oncology, organized by OncoDaily) Dr. Tian Zhang (Tian Zhang, MD, MHS, FASCO (@tiansterzhangmd.bsky)) (UT Southwestern) shared key updates on the current standard of care in metastatic RCC: Dr. Tian Zhang (UT Southwestern) highlighted: 🔹 IO/IO → durable,

🚨 Highlights from VIRO 2025 (Global Voices in Renal Oncology, organized by OncoDaily)

Dr. Tian Zhang (<a href="/TiansterZhang/">Tian Zhang, MD, MHS, FASCO (@tiansterzhangmd.bsky)</a>) (UT Southwestern) shared key updates on the current standard of care in metastatic RCC:

Dr. Tian Zhang (UT Southwestern) highlighted:

🔹 IO/IO → durable,
OncoDaily IO (@oncodailyio) 's Twitter Profile Photo

Advancing CAR T-Cell Therapy in Solid Tumors - Humaid Al-Shamsi Prof.Dr.Humaid Al-Shamsi 🇦🇪 oncodaily.com/science/humaid… #OncoDaily #Oncology #Cancer #Health #Medicine #MedX #MedEd #MedNews CancerWorld

Advancing CAR T-Cell Therapy in Solid Tumors - Humaid Al-Shamsi

<a href="/alshamsi2000/">Prof.Dr.Humaid Al-Shamsi 🇦🇪</a> 

oncodaily.com/science/humaid…

#OncoDaily #Oncology #Cancer #Health #Medicine #MedX #MedEd #MedNews <a href="/CancerWorldmag/">CancerWorld</a>
OncoDaily IO (@oncodailyio) 's Twitter Profile Photo

Adjuvant Immunotherapy in Urology – The Critical Challenge of irAEs - Giuseppe Banna Giuseppe Banna oncodaily.com/science/giusep… #OncoDaily #Oncology #Cancer #Health #Medicine #MedX #MedEd #MedNews CancerWorld

Adjuvant Immunotherapy in Urology – The Critical Challenge of irAEs - Giuseppe Banna

<a href="/gbanna74/">Giuseppe Banna</a> 

oncodaily.com/science/giusep…

#OncoDaily #Oncology #Cancer #Health #Medicine #MedX #MedEd #MedNews <a href="/CancerWorldmag/">CancerWorld</a>
OncoDaily IO (@oncodailyio) 's Twitter Profile Photo

A Novel Anti-B7 H3 Affibody with Strong Potential for AML therapy - Natalia Baran Frontiers oncodaily.com/voices/anti-b7… #Cancer #ImmuneOnc #IO #ImmunoOncology #Immunotherapy #MedEd #MedX #MedNews #Health #Medicine #OncoDaily #Oncology

OncoDaily IO (@oncodailyio) 's Twitter Profile Photo

Comprehensive Overview of Immunotherapy for Lung Cancer - Vandana Mahajan Lung Connect India oncodaily.com/voices/vandana… #Cancer #ImmuneOnc #IO #ImmunoOncology #Immunotherapy #MedEd #MedX #MedNews #Health #Medicine #OncoDaily #Oncology

Comprehensive Overview of Immunotherapy for Lung Cancer - <a href="/oceanblue11oct/">Vandana Mahajan</a> 

<a href="/LungConnectIN/">Lung Connect India</a> 

oncodaily.com/voices/vandana…

#Cancer #ImmuneOnc #IO #ImmunoOncology #Immunotherapy #MedEd #MedX #MedNews #Health #Medicine #OncoDaily #Oncology